Email
Print
Collagen Peptide & Gelatin Market - Forecast(2024 - 2030)
Collagen Peptide & Gelatin Market Overview
Collagen
Peptide & Gelatin Market size is estimated to reach $5.8 billion by 2027,
growing at a CAGR of 7.4% during the forecast period 2022-2027. Gelatin is a protein
made up of animal collagen mostly from cows and pigs. Collagen is made up of
amino acids which consist of glycine, proline, and hydroxyproline, and is mostly
found in connective tissue, skin, tendon, bone, and cartilage. Collagen peptide
is easy to digest highly bioactive source of collagen. Collagen peptide is used
in dairy, confectionery, food and beverages, meat, and seafood products, and is
widely employed in the pharmaceuticals industry. Gelatin is a colorless,
transparent, flavorless, and brittle food ingredient made from collagen, which
can be found in a variety of animal body parts. Pharmaceutical medications,
food, photography, vitamin capsules, and cosmetic manufacturers all employ it
as a gelling agent. Gelatin is also one of the most commonly used food
additives, especially in the confectionery industry and in a number of dairy
goods, such as cream desserts, yogurts, and a wide range of low-fat dairy
products, where it is used to improve product stability and texture. Cosmetics,
food and beverage, pharmaceuticals, and nutraceuticals industries all use peptides
and gelatine. Consumption of collagen or peptides improves the collagen level
of the body and helps in reducing bone problems such as osteoarthritis,
osteoporosis, and others, improving bone density, and enhancing gut health. With
an increase in age, loss in integrity of collagen bond occurs which invites
aging signs and bone problems.
The
expanding population of the elderly mainly demands collagen peptides and
gelatin which is set to drive the Collagen Peptide & Gelatin Market. The increase
in alcohol consumption resulting in collagen deficiency in the body, which can
be boosted by peptide and gelatin-based nutraceuticals is set to propel the
growth of the Collagen Peptide & Gelatin Market during the forecast period
2022-2027. This represents the Collagen Peptide & Gelatin Industry Outlook.
Collagen Peptide & Gelatin Market Report Coverage
The
report: “Collagen Peptide & Gelatin Market Forecast
(2022-2027)", by Industry ARC covers an in-depth analysis of the
following segments of the Collagen Peptide & Gelatin Market.
Key Takeaways
- Geographically, North America Collagen Peptide & Gelatin Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the existence of well-entrenched collagen manufacturing facilities and the application of progressive extraction methodologies in the North American region.
- Collagen Peptide & Gelatin Market growth is being driven by the exacting R&D activities in regenerative medicine and wound healing and the development in commercialization of new collagen-based drug delivery systems. However, an increasing count of slaughtered animals adversely impacting animal welfare and a raising vegan population are some of the major factors hampering the growth of the Collagen Peptide & Gelatin Market.
- Collagen Peptide & Gelatin Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Collagen Peptide & Gelatin Market report.
Collagen Peptide & Gelatin Market: Market Share (%) By Region, 2021
For more details on this report - Request for Sample
Collagen Peptide & Gelatin Market Segment Analysis - By Source
The Collagen Peptide & Gelatin Market based on the source can be further segmented into Bovine, Sheep, Porcine, Chicken, Marine, and Others. The Bovine Segment held the largest market share in 2021. This growth is owing to the wide application of bovine-based peptides and collagen in various industries such as food and beverages, cosmetics, and pharmaceuticals. The global gelatin by volume reached 447,300 Tonnes in 2021 and is anticipated to reach 496,470 tonnes in 2027. As per the latest forecast by the Economic Research Service of the U.S Department of Agriculture, total red meat and poultry production will rise to 106.25 million pounds, and per capita consumption is 222.4 pounds in 2022. This kind of increasing production and consumption is further propelling the growth of the Bovine segment. Furthermore, the Porcine segment is estimated to grow with the fastest CAGR of 8.1% during the forecast period 2022-2027 owing to the increasing preference for porcine-based nutritional products in the market and new innovative products launched by key market players.
Collagen Peptide & Gelatin Market Segment Analysis - By Application
The Collagen
Peptide & Gelatin Market based on the application can be further segmented into
Food And Beverages, Pharmaceuticals, Cosmetics, Nutraceuticals, and Others. The Food
And Beverages Segment held the largest market share in 2021. This growth is
owing to the increase in demand for various bovine and porcine collagen
peptides and gelatin for application in the food and beverages industry. The rising
demand for healthy food and functional beverages as well as various R&D
activities and new product launches by key market players are further
propelling the growth of this segment.
Furthermore, the
Pharmaceuticals segment is estimated to grow with the fastest CAGR of 8.3%
during the forecast period 2022-2027 owing to the wide application of collagen
peptides in the pharmaceuticals industry, being employed as collagen shield in
ophthalmology, sponges for burns or wounds, for protein and drug delivery, as
controlling material for transdermal delivery, and nanoparticles for gene
delivery and basic matrices for cell structure system.
Collagen Peptide & Gelatin Market Segment Analysis - By Geography:
The
Collagen Peptide & Gelatin Market based on geography can be further segmented
into North America, Europe, Asia-Pacific, South America and Rest of the World.
North America (Collagen Peptide & Gelatin Market) held the largest share with
35% of the overall market in 2021. The growth of this region is owing to the increasing
consumer awareness and the expanding population of the elderly in America. As
per a CDC (Centers For Disease Control And Prevention) report, by 2040, about
78 million (26%) of the U.S population would have doctor-diagnosed arthritis
and from a previous study, it is found that people aged 65 or above would have the
highest chances of about 49.6% of doctor-diagnosed arthritis. Consumption of peptides
and gelatin helps to reduce the severity of these diseases which is further propelling
the growth of the Collagen Peptide & Gelatin Market in
the North American region.
Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like the increasing demand for nutritious food by a large population. The Food and Agricultural Organization (FAO) warned 20 countries about acute food insecurity from February to May 2022. In Afghanistan, a total of 8.7 million people were affected by acute food insecurity in March 2022. The increasing demand for nutritious food is therefore driving the growth of the Collagen Peptide & Gelatin Market in the Asia-Pacific region.
Collagen Peptide & Gelatin Market Drivers
Increase In Consumption Of Healthy Diet Is Driving The Collagen Peptide & Gelatin Market
Consumers
mostly prefer to consume healthy nutritious food. Collagen is mostly used in
the food and beverages industry. Collagen has been applied as protein dietary
supplements, carriers in the meat processing, edible film and coatings of
products, and food additive to improve product quality. Also, gelatin is a
common ingredient in soups, broths, sauces, gummy candies, and marshmallows.
The increasing demand for fat-free, gluten-free bakery products as a result of the
rise in celiac disease creates opportunities for the collagen peptide &
gelatin market. According to National Center for Biotechnology Information (NCBI)
research, the number of cases of Classical, Non-classical, and Sub-clinical celiac disease in the U.S. in 2020 was 189,464, 364,893, and
147,361 respectively. As per Harvard Th. Chan School Of Public Health, a
gluten-free diet is a singular treatment for 1-2% of Americans enduring celiac disease. The increase in consumption of a healthy diet is therefore
driving the Collagen Peptide & Gelatin Market during the forecast period 2022-2027.
Increasing Elderly Population And Rising Predominance Of Genetic Diseases Are Propelling The Growth Of The Collagen Peptide & Gelatin Market
The
increasing population of the elderly around the world creates a need for taking
care of such people who frequently need medical help. With increasing age, a number
of health complications are arising in the body like diabetes, blood pressure,
cardiovascular diseases, and others. According to the department of economics
and social welfare of the United Nations, 727 million people all over the world
are aged 65 and over in 2020, and it will reach up to 1.5 billion by 2050.
Also, the incidence of rare genetic diseases is increasing over the past few
years as a result of changes in lifestyle, changing climatic conditions, and
other such factors. As per National Human Genome Research Institute, about 350
million people around the world live with rare genetic diseases, and only
200,000 of them get diagnosed. The increasing elderly population and rising
predominance of genetic diseases are therefore propelling the growth of the
Collagen Peptide & Gelatin Market during the forecast period 2022-2027.
Collagen Peptide & Gelatin Market Challenges
Risk Of Disease Transmission from Bovine and Porcine Collagen And Influence of Religious And Cultural Beliefs Hampers Market Growth
A case of classical bovine spongiform encephalopathy (BSE) was verified in Somerset, England, in September 2021 by the Chief Veterinary Officer and the Animal and Plant Health Agency (APHA). BSE is a disease that affects cows' nervous systems. Variant Creutzfeldt-Jakob disease (vCJD) is a type of BSE that affects people. In 2019, 232 people worldwide are known to have become sick with vCJD, and unfortunately, they all have died. It is thought that they got the disease by eating food made from cows sick with BSE. Also, Cow and Pig come under the religious view of Hindus and Muslims. Islam is the second-largest followed religion in the world followed by Hinduism. Owing to the increasing number of followers of these two religions and their beliefs, there can be an adverse impact on the progress of the Collagen Peptide & Gelatin Market. These issues are restraining the growth of the Collagen Peptide & Gelatin Market.
Collagen Peptide & Gelatin Industry Outlook
Product launches, mergers and acquisitions, joint ventures,
and geographical expansions are key strategies adopted by players in the Collagen Peptide & Gelatin Market. The top 10- Collagen Peptide & Gelatin Market companies
are:
- Amicogen, Inc.
- BioCell Technology LLC
- Capsugel Belgium NV
- Catalent, Inc.
- ChinaTech Peptide Co. Ltd.
- GELITA AG
- InterHealth Nutraceuticals, Inc.
- Nitta Gelatin, Inc
- Norland Products, Inc.
- Rousselot
Recent Developments
- In March 2022, Amicogen Inc. started construction on a cell culture medium factory. This was done to produce biopharmaceuticals in Zone 5 of Songdo International City, Korea. After completion of the project, the company will be able to produce 4 million liters of media per year.
- In November 2021, BioCell Technologies developed the platform RapidNA, to quickly produce a large amount of RNA in New Zealand. The production occurs in the south Auckland production facility. In addition to the RNA platform, BioCell will install New Zealand’s first high-speed automated filling machine at its Papatoetoe production facility with the ability to fill up 100 million vaccine doses on site.
- In October 2020, Lonza AG (Basel, Switzerland) declared a CHF 85 million (~$93 million USD) financing in its Capsules and Health Ingredients (CHI) Division, a dosage-form delivery partner to the biopharma and health nutrition industry. The financing will allow the firm to extend its overall production capacity of capsules within CHI’s Capsugel portfolio by 30 billion capsules yearly while keeping up the high-quality standards with Lonza’s Sigma Series. The novel extension includes eight global Lonza sites.